Tempest Therapeutics(TPST)

Search documents
Tempest Therapeutics(TPST) - 2018 Q4 - Annual Report
2019-03-29 21:36
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35890 Millendo Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 45-1472564 (State or other jurisdiction of incorpora ...
Millendo Therapeutics (MLND) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
2019-03-11 19:44
May 2018 Presentation to Corporate Presentation Lorem Ipsum Dolor March 2019 Cautionary Statement Regarding Forward-Looking Statements Certain statements contained in this presentation regarding matters that are not historical facts, are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include statements regarding management's intentions, plans, beliefs, expecta ...